Cirrhosis Treatment: Albumin and Enoxaparin Study

We are testing a new combination therapy of albumin and enoxaparin for patients with decompensated cirrhosis at high risk of complications. The study aims to assess safety and explore how this treatment may affect the disease.

6-12 months ≤5 visits Efficacy phase (II)No Placebo Standard Medicines InjectionHepatologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Albutein

Albutein is a blood protein solution used to restore blood volume and treat low blood protein after surgery or serious illness.

Enoxaparina Rovi

Enoxaparina Rovi is a medicine used to prevent and treat harmful blood clots.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Enoxaparin

Enoxaparin is a substance that helps prevent and treat blood clots by thinning the blood.

Enoxaparin Sodium

Enoxaparin sodium is a substance that helps prevent and treat blood clots by thinning the blood.

Human Serum Albumin

Human serum albumin is a blood protein used to restore blood volume and maintain blood pressure after severe fluid loss or low albumin levels.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Albiomin

Albumeon

Albumin Baxalta

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Hopital Beaujon

Digestivo

Clichy, France

Universitaetsklinikum Muenster AöR

Digestive

Münster, Germany

Universitaetsklinikum Aachen AöR

Hepatology

Vaals, Germany

Sponsor: European Foundation For The Study Of Chronic Liver Failure

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.